0001104659-16-107420.txt : 20160324
0001104659-16-107420.hdr.sgml : 20160324
20160324160752
ACCESSION NUMBER: 0001104659-16-107420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160322
FILED AS OF DATE: 20160324
DATE AS OF CHANGE: 20160324
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1214
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones William Benton
CENTRAL INDEX KEY: 0001664506
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 161527136
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD, SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
a4.xml
4
X0306
4
2016-03-22
0
0001626971
Corvus Pharmaceuticals, Inc.
CRVS
0001664506
Jones William Benton
CORVUS PHARMACEUTICALS, INC.
863 MITTEN ROAD, SUITE 102
BURLINGAME
CA
94010
0
1
0
0
VP Pharmaceutical Development
Stock Option (Right to Buy)
15.00
2016-03-22
4
A
0
60000
0.00
A
2026-03-22
Common Stock
60000
60000
D
The underlying shares subject to the option vest and become exercisable as to one-forty-eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from March 22, 2016, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
2016-03-24